In this study, we identified a notable enrichment of Rgs2+CD8+ T cells derived from T1_CD8_Ifit1_T cells in MSS‐CRLM tumor tissue following RegoNeo treatment compared to other treated groups. This evidence concerns the gene RGS2 and neoplasm.